Overview of study participants
| Country/region | Disease focus | Number of interviews | Number and type of interview participants | Language of interview(s) | |
| Belarus | TB | 2 | 5 | NTP | English/Russian* |
| HIV | 1 | 4 | UNAIDS, GF | English/Russian* | |
| Botswana | HIV | 1 | 3 | NAP | English |
| Eastern Europe and Central Asia | HIV | 1 | 1 | GF | English |
| Eswatini | HIV | 1 | 5 | NAP | English |
| Kyrgyzstan | HIV | 1 | 2 | NAP, UNAIDS | English/Russian* |
| Latin American and Caribbean | HIV | 1 | 1 | GF | English |
| Malawi | HIV | 2 | 1 | MOH † | English |
| 1 | GF | English | |||
| TB | 1 | 4 | NTP | English | |
| Mozambique | TB | 1 | 5 | MOH | English/Portuguese* |
| Peru | TB | 1 | 8 | MOH | Spanish ‡ |
| Ukraine | HIV | 2 | 2 | MOH | English/Ukrainian* |
| 2 | UNAIDS | English | |||
| Zimbabwe | HIV | 1 | 10 | MOH, NAP | English |
*Interpreter present.
†Technical consultant.
‡Facilitated in Spanish and notes translated.
GF, Global Fund; MOH, Ministry of Health; NAP, National AIDS Programme; NTP, National TB Programme (or local equivalent); TB, tuberculosis .